ESC 365 - Epigenetic therapy reduces angiotensin-II induced cardiac hypertrophy and fibrosis

HFA Premium Access

Epigenetic therapy reduces angiotensin-II induced cardiac hypertrophy and fibrosis

Session: Poster Session 1 - Basic Science - Cellular biology

Topic: HFpEF - Heart failure with preserved ejection fraction

Speaker: Doctor A. Russell-Hallinan (Belfast, GB)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Adam Russell-Hallinan

Queen's University of Belfast, Belfast (United Kingdom of Great Britain & Northern Ireland)

0 follower

9 more presentations in this session

Effects of chronic ACE inhibitor treatment on a translational model of heart failure with preserved ejection fraction

Speaker: Miss N. Harouki (Issy Les Moulineaux, FR)

Increased plasma clusterin levels in patients with left ventricular remodeling after myocardial infarction has cardiac origin and is due to a defect in proteasome activity

Speaker: Doctor A. Turkieh (Lille, FR)

Angiotensin 1-7 might be a new solution in the treatment of chronic heart failure

Speaker: Doctor A. Kazak (Minsk, BY)

SIRT1 protects the heart from endoplasmic reticulum stress-induced apoptosis through eIF2a deacetylation

Speaker: Ms J. Pires Da Silva (Chatenay-Malabry, FR)

Influence of iron availability in the normoxic versus hypoxic conditions on the morphology and atrophy of skeletal myocytes.

Speaker: Doctor K. Kobak (Oklahoma City, US)

Access the full session

Poster Session 1 - Basic Science - Cellular biology

Speakers: Doctor A. Russell-Hallinan, Miss N. Harouki, Doctor A. Turkieh, Doctor A. Kazak, Ms J. Pires Da Silva...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources